SN
Seshadri Neervannan
DELAYED 1 MONTH
Chief Operating Officer
Tarsus Pharmaceuticals, Inc.
Filings
3
Companies
1
Latest
Mar 15, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
—
Tarsus Pharmaceuticals, Inc.
Seshadri Neervannan
Chief Operating Officer
Option Exercise
—
26,287 sh
Mar 17 8:35 PM
Mar 15, 2026
56
Tarsus Pharmaceuticals, Inc.
Seshadri Neervannan
Chief Operating Officer
Sale
$641.4K
8,366 sh
Mar 5 9:03 PM
Mar 4, 2026